{
    "nct_id": "NCT06577311",
    "official_title": "An Investigator Initiated Study to Evaluate the Safety and Efficacy of Aminolevulinic Acid Hydrochloride Topical Gel, 10% (Ameluz ®) With RhodoLED-XL® Red Light in the Treatment of Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)\"",
    "inclusion_criteria": "* Must be an adult (18 years of age or older)\n* Must have a recently diagnosed (no more than six months from first study visit) facial SCCis lesion that meets surgery excision size requirements\n* Cannot have other dermatological disease in the SCCis target area\n* Must be willing to follow study instructions and complete study requirements, including not using non-approved lotions and creams on the treatments areas\n* Voluntary written consent required\n* Allow photographs of the area of skin cancer being treated on the face\n* Agree to use acceptable forms of birth control. If female, cannot be pregnant before and during the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pregnant or lactating\n* Sensitive to any of the study treatment ingredients\n* Medical laboratory evidence of other non-SCCis tumor in the target lesion biopsy specimen\n* History of recurrence if the target SCCis lesion\n* Evidence of dermatological disease or skin condition in the treatment area\n* Medical laboratory evidence of growth patterns in the target lesion biopsy specimen\n* Chronic medical condition that in the Investigators opinion will interfere in the trial or affect participant safety.",
    "miscellaneous_criteria": ""
}